BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26817957)

  • 21. Platelet RNA sequencing for cancer screening in patients with unprovoked venous thromboembolism: a prospective cohort study.
    Mulder FI; Kraaijpoel N; Carrier M; Guman NA; Jara-Palomares L; Di Nisio M; Ageno W; Beyer-Westendorf J; Klok FA; Vanassche T; Otten HB; Cosmi B; Wolde MT; In 't Veld SGJG; Post E; Ramaker J; Zwaan K; Peters M; Delluc A; Kamphuisen PW; Sanchez-Lopez V; Porreca E; Bossuyt PMM; Büller HR; Wurdinger T; Best MG; van Es N
    J Thromb Haemost; 2023 Apr; 21(4):905-916. PubMed ID: 36841648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occult cancer in patients with unprovoked venous thromboembolism: A nested case-control study.
    Sánchez-López V; Marín-Romero S; Ferrer-Galván M; Elías-Hernández T; Lobo Beristain JL; Ballaz Quincoces A; Jara-Palomares L; Rodríguez Martorell FJ; Castro MJ; Marín Hinojosa C; López-Campos JL; Otero-Candelera R
    Am J Clin Pathol; 2024 May; 161(5):501-511. PubMed ID: 38340336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for occult cancer: where are we in 2020?
    Marín-Romero S; Jara-Palomares L
    Thromb Res; 2020 Jul; 191 Suppl 1():S12-S16. PubMed ID: 32736769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Occult cancer-related first venous thromboembolism is associated with an increased risk of recurrent venous thromboembolism.
    Gran OV; Braekkan SK; Paulsen B; Skille H; Rosendaal FR; Hansen JB
    J Thromb Haemost; 2017 Jul; 15(7):1361-1367. PubMed ID: 28440069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extensive Computed Tomography versus Limited Screening for Detection of Occult Cancer in Unprovoked Venous Thromboembolism: A Multicenter, Controlled, Randomized Clinical Trial.
    Prandoni P; Bernardi E; Valle FD; Visonà A; Tropeano PF; Bova C; Bucherini E; Islam MS; Piccioli A
    Semin Thromb Hemost; 2016 Nov; 42(8):884-890. PubMed ID: 27764880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence of Cancer after a Second Unprovoked Venous Thromboembolic Event.
    Rézig S; Mao RL; Couturaud F; Lacut K; Delluc A
    Thromb Haemost; 2019 Mar; 119(3):490-495. PubMed ID: 30685873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Real-world experience with limited screening for occult malignancy in patients presenting with spontaneous venous thromboembolism: a single-centre, retrospective cohort study.
    Grainger BT; McCrea TA; Eaddy N; Ockelford P; Young L
    Intern Med J; 2022 Mar; 52(3):491-494. PubMed ID: 35307933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Positron emission tomography combined with computed tomography as a screening tool for occult malignancy in patients with unprovoked venous thromboembolism: an observational study.
    Chauchard M; Benali K; Papo T; Sacre K
    Medicine (Baltimore); 2014 Nov; 93(21):e110. PubMed ID: 25380083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for occult cancer after unprovoked venous thromboembolism: Assessing the current literature and future directions.
    Patel SS; Tao D; McMurry HS; Shatzel JJ
    Eur J Haematol; 2023 Jan; 110(1):24-31. PubMed ID: 36192850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The long-term risk of cancer in patients with a first episode of venous thromboembolism.
    Douketis JD; Gu C; Piccioli A; Ghirarduzzi A; Pengo V; Prandoni P
    J Thromb Haemost; 2009 Apr; 7(4):546-51. PubMed ID: 19143921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Conundrum of Occult Cancer Screening in Venous Thromboembolism: Lessons from the REMOTEV Registry.
    Cordeanu EM; Jambert L; Tousch J; Mirea C; Delatte A; Younes W; Woehl B; Harter C; Frantz AS; Hamade A; Schini-Kerth V; Ohlmann P; Andres E; Stephan D
    Medicina (Kaunas); 2022 Jul; 58(7):. PubMed ID: 35888632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Unprovoked venous thromboembolism : should we look for occult cancer ?].
    Carcaterra A; Serratrice J; Righini M; Robert-Ebadi H
    Rev Med Suisse; 2018 Oct; 14(623):1840-1843. PubMed ID: 30329229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.
    Robertson L; Yeoh SE; Stansby G; Agarwal R
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD010837. PubMed ID: 28832905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Venous thromboembolism and occult malignancy.
    Otten HM; Prins MH
    Thromb Res; 2001 Jun; 102(6):V187-94. PubMed ID: 11516452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening for Occult Cancer in Patients With Unprovoked Venous Thromboembolism: A Systematic Review and Meta-analysis of Individual Patient Data.
    van Es N; Le Gal G; Otten HM; Robin P; Piccioli A; Lecumberri R; Jara-Palomares L; Religa P; Rieu V; Rondina M; Beckers MM; Prandoni P; Salaun PY; Di Nisio M; Bossuyt PM; Büller HR; Carrier M
    Ann Intern Med; 2017 Sep; 167(6):410-417. PubMed ID: 28828492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk scores for occult cancer in patients with unprovoked venous thromboembolism: Results from an individual patient data meta-analysis.
    Mulder FI; Carrier M; van Doormaal F; Robin P; Otten HM; Salaun PY; Büller HR; Le Gal G; van Es N
    J Thromb Haemost; 2020 Oct; 18(10):2622-2628. PubMed ID: 32654348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased risk and severity of unprovoked venous thromboembolism with clustering cardiovascular risk factors for atherosclerosis: Results of the REMOTEV registry.
    Gaertner S; Cordeanu EM; Mirea C; Frantz AS; Auger C; Bilbault P; Ohlmann P; Schini-Kerth V; Stephan D
    Int J Cardiol; 2018 Feb; 252():169-174. PubMed ID: 29169908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Real-world incidence of cancer following a first unprovoked venous thrombosis: Results from the EPIGETBO study.
    Delluc A; Ianotto JC; Tromeur C; De Moreuil C; Couturaud F; Lacut K; Le Moigne E; Louis P; Thereaux J; Metges JP; Mottier D
    Thromb Res; 2018 Apr; 164():79-84. PubMed ID: 29522910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost effectiveness of the addition of a comprehensive CT scan to the abdomen and pelvis for the detection of cancer after unprovoked venous thromboembolism.
    Coyle K; Carrier M; Lazo-Langner A; Shivakumar S; Zarychanski R; Tagalakis V; Solymoss S; Routhier N; Douketis J; Coyle D
    Thromb Res; 2017 Mar; 151():67-71. PubMed ID: 28160670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of Recurrent Venous Thromboembolism: A Danish Nationwide Cohort Study.
    Albertsen IE; Nielsen PB; Søgaard M; Goldhaber SZ; Overvad TF; Rasmussen LH; Larsen TB
    Am J Med; 2018 Sep; 131(9):1067-1074.e4. PubMed ID: 30266273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.